Watch Ticker

Aptose Biosciences, Inc.

Go to Aptose Biosciences, Inc. Website

$1.71

(%)

Live

Previous Close

$1.71

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

Day Vol.

Previous Day Vol.

Currency

Primary Exchange

Nasdaq

...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Aptose Announces Publication of Preclinical Data in AACR Journal Demonstrating Tuspetinib’s Unique Mechanism of Action and Synthetic Lethality on AML Cells When Combined with Venetoclax

Aptose Biosciences announced the publication of preclinical data for its lead compound tuspetinib, which demonstrates its unique mechanism of action and synthetic lethality when combined with venetoclax in treating acute myeloid leukemia (AML).

Related tickers: APTO.

Read Full Article

N/A - Aptose Clinical Data Featured in Poster Presentation at the 2024 ASH Annual Meeting Support Tuspetinib Triple Drug Therapy for Newly Diagnosed AML

Aptose Biosciences presented clinical data on its lead compound tuspetinib (TUS) at the 2024 ASH Annual Meeting. The data supports the advancement of the TUS+VEN+AZA triplet therapy for frontline treatment of newly diagnosed AML patients ineligible for intensive chemotherapy.

Related tickers: APTO.

Read Full Article

Trending Tickers

Please sign in to view